ACI Formulations PLC (DSE:ACIFORMULA)

ACI Formulations Revenue

ACI Formulations had revenue of 1.30B BDT in the quarter ending March 31, 2025, with 5.39% growth. This brings the company's revenue in the last twelve months to 5.01B, up 0.65% year-over-year. In the fiscal year ending June 30, 2024, ACI Formulations had annual revenue of 4.94B, down -0.49%.

• Revenue (ttm): 5.01B
• Revenue Growth: +0.65%
• P/S Ratio: 1.29
• Revenue / Employee: 4.84M
• Employees: 1,034
• Market Cap: 6.44B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	4.94B	-24.35M	-0.49%
Jun 30, 2023	4.96B	712.39M	16.77%
Jun 30, 2022	4.25B	382.88M	9.91%
Jun 30, 2021	3.86B	440.49M	12.86%
Jun 30, 2020	3.42B	-628.33M	-15.51%